Drug––diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics Workshop

By Hinman Lois   Spear Brian   Tsuchihashi Zenta   Kelly James   Bross Peter   Goodsaid Federico   Kalush Francis  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 127-136

Future Medicine

Access to resources Recommend Favorite

Perspectives on development of a combination pharmacogenomic diagnostic and drug product

By McCamish Mark   Izumi Raquel  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 1045-1049

Future Medicine

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas   Chesler Louis   Hargrave Darren   Eccles Suzanne A   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

Anti-Cancer Drug Discovery and Development Summit

By Blakey David C  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1577-1582

Informa Healthcare

Access to resources Recommend Favorite

Cancer Chemoprevention Drug Development Strategies for Resveratrol

By Steele Vernon E.   Wargovich Michael J.   McKee Kathy   Sharma Sheela   Wilkinson Betty P.   Wyatt Gail P.   Gao Pu   Kelloff Gary J.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 36, Iss. 1, 1998-12 ,pp. : 62-68

Informa Healthcare

Access to resources Recommend Favorite